Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Improving tolerability of immunosuppressive regimens.

A MacDonald

    Transplantation
    |February 9, 2002
    PubMed
    Summary

    Sirolimus offers a promising alternative to calcineurin inhibitors (CNIs) and corticosteroids in transplantation. This immunosuppressant may reduce nephrotoxicity and improve patient quality of life without compromising allograft survival.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The effects of anthropogenic sound on behaviour and physiology in female Port Jackson sharks Heterodontus portusjacksoni (Elasmobranchii).

    Marine pollution bulletin·2025
    Same author

    Multicenter study on long-term growth in patients with phenylketonuria.

    Orphanet journal of rare diseases·2025
    Same author

    Older Lineages of Vascular Plants in Wetlands Dominate in Habitats That Are More Ubiquitous Across the Region: A Case Study in Southern Africa.

    Ecology and evolution·2025
    Same author

    Nutritional profiling of foods for Phenylketonuria.

    Scientific reports·2025
    Same author

    European guidelines on diagnosis and treatment of phenylketonuria: First revision.

    Molecular genetics and metabolism·2025
    Same author

    Dissolved organic matter quantity and quality response of tropical rainforest headwater rivers to the transition from dry to wet season.

    Scientific reports·2024

    Area of Science:

    • Immunology
    • Pharmacology
    • Transplantation Medicine

    Background:

    • Calcineurin inhibitors (CNIs) and corticosteroids, standard immunosuppressants, are linked to adverse effects impacting quality of life and long-term transplant outcomes.
    • Nephrotoxicity is a significant concern with CNI therapy, driving the search for safer alternatives.

    Purpose of the Study:

    • To review sirolimus as an alternative immunosuppressive agent in transplantation.
    • To evaluate its mechanism of action, clinical efficacy, and potential antiproliferative and antineoplastic properties.
    • To assess its role in augmenting or replacing CNIs and corticosteroids.

    Main Methods:

    • Review of key clinical studies involving sirolimus in solid organ transplantation.
    • Analysis of combination therapy with sirolimus and tacrolimus.
    • Examination of sirolimus as a primary immunosuppressive agent.

    Main Results:

    • Sirolimus, alone or in combination with tacrolimus, shows potential in preventing acute rejection.
    • Combination therapy may reduce CNI-associated nephrotoxicity.
    • Sirolimus as a base therapy could avoid CNI-related nephrotoxicity while maintaining robust rejection protection.

    Conclusions:

    • Sirolimus may improve transplant patient quality of life by mitigating nephrotoxicity.
    • It offers a viable option for immunosuppression, potentially enhancing long-term outcomes without increasing rejection risk.

    Related Experiment Videos